MedPath
HSA Approval

GLUCOSE INTRAVENOUS INFUSION BP 10%

SIN06307P

GLUCOSE INTRAVENOUS INFUSION BP 10%

GLUCOSE INTRAVENOUS INFUSION BP 10%

July 2, 1991

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05CX01

glucose

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

Active Ingredients

GLUCOSE MONOHYDRATE

11 g/100 ml

Glucose

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLUCOSE INTRAVENOUS INFUSION BP 10% - HSA Approval | MedPath